Bulldog Investors’s Organogenesis Holdings ORGO Stock Holding History

Bulldog Investors’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-329,683	Closed	-$3.43M	–	159
2018 Q3	$3.43M	Buy	329,683 +6,705	+2%	+$67.7K	0.96%	35
2018 Q2	$3.24M	Buy	322,978 +20,842	+7%	+$209K	0.85%	35
2018 Q1	$2.99M	Hold	302,136	–	–	0.82%	34
2017 Q4	$3M	Buy	302,136 +53,700	+22%	+$533K	0.81%	37
2017 Q3	$2.48M	Hold	248,436	–	–	0.72%	37
2017 Q2	$2.45M	Sell	248,436 -3,564	-1%	-$35K	0.62%	36
2017 Q1	$2.49M	Buy	+252,000	New	+$2.49M	0.64%	34

Bulldog Investors's ORGO Position: Q4 2018 in Review

Bulldog Investors sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 329,683 shares — an estimated $3.43M sold.

Bulldog Investors first reported a position in ORGO in Q1 2017 and held it in 7 quarters. The position peaked at $3.43M in Q3 2018. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

Bulldog Investors reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
Bulldog Investors sold 329,683 Organogenesis Holdings shares in Q4 2018, an estimated $3.43M.
Bulldog Investors first reported a position in Organogenesis Holdings in Q1 2017 and held it in 7 quarters.
Bulldog Investors's Organogenesis Holdings position peaked at $3.43M in Q3 2018.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Bulldog Investors's 13F filing for Q4 2018, filed 14 Feb 2019.